Sana Bloch
Payments from drug & device makers
Across 218 payments — averaging $23.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EMD Serono, Inc.$753
- AstraZeneca$655
- Supernus Pharmaceuticals, Inc.$536
- AbbVie$447
- Teva Pharmaceuticals USA, Inc.$377
- Sunovion Pharmaceuticals Inc.$323
- plus $2K from 21 others
What the payments were for
- Speaking & faculty fees$150%
- Food & beverage$5,16699%
- Education$190%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| EMD Serono, Inc. | 22 | $753 |
| AstraZeneca(2 entities) | 19 | $655 |
| Supernus Pharmaceuticals, Inc. | 11 | $536 |
| AbbVie(2 entities) | 23 | $447 |
| Teva Pharmaceuticals USA, Inc. | 25 | $377 |
| Sunovion Pharmaceuticals Inc. | 17 | $323 |
| Novartis | 14 | $272 |
| Biogen | 8 | $216 |
| Sanofi | 9 | $188 |
| Amgen(2 entities) | 9 | $179 |
| Abbott | 2 | $160 |
| UCB, Inc. | 9 | $156 |
| Kyowa Kirin, Inc. | 9 | $151 |
| Acorda Therapeutics, Inc | 3 | $142 |
| Argenx US, Inc. | 5 | $105 |
| Lilly USA, LLC | 7 | $101 |
| SK Life Science, Inc. | 5 | $91 |
| Acadia Pharmaceuticals Inc | 6 | $86 |
| Johnson & Johnson | 2 | $58 |
| Amneal Pharmaceuticals LLC | 3 | $41 |
| Pfizer | 2 | $37 |
| Vertical Pharmaceuticals, LLC | 2 | $30 |
| MDD US Operations, LLC | 2 | $28 |
| Bristol Myers Squibb | 1 | $20 |
| Neurocrine Biosciences, Inc. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,200 in reported general payments places this provider in the 65th percentile of 1,623 neurology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aimovig AutoinjectorErenumab-Aooe | 14 | $9,833 |
| Rivastigmine | 98 | $6,410 |
| Doxepin Hcl | 30 | $4,884 |
| Gabapentin | 119 | $2,627 |
| Donepezil Hcl | 447 | $2,426 |
| AmantadineAmantadine Hcl | 62 | $1,781 |
| Nortriptyline Hcl | 139 | $1,172 |
| Primidone | 45 | $1,147 |
| Lacosamide | 13 | $1,139 |
| Galantamine Hbr | 33 | $1,115 |
| Memantine Hcl | 104 | $1,030 |
| Pregabalin | 11 | $815 |
| Oxcarbazepine | 17 | $644 |
| Divalproex Sodium ErDivalproex Sodium | 26 | $585 |
| Carbamazepine | 13 | $572 |
Paid to pharmacies, not to this prescriber.
Other neurology in Bronx
- Richard LiptonBronx$1.6M
- Christian GrommesNew York$9.9M
- Ilya KisterNew York$9.5M
- E DorseyNew York$8.5M
- Lauren SchaffNew York$8.2M
- Richard HolubAlbany$6.3M
- Martin SadowskiNew York$5.4M
- Lawrence HonigNew York$4.9M
- Laszlo MechtlerAmherst$4.3M
- Bennett MyersAmherst$3.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.